[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365752-105":59,"doc-detail-365752-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","molecular-cancer-guide-a-prospective-cohort-study-for-blood-based-early-detection-of-gastrointestinal-cancers-using-targeted-dna-methylation-and-fragmentomics-sequencing","Molecular Cancer - GUIDE: a prospective cohort study for blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing","","Gastrointestinal (GI) cancers remain highly prevalent and lethal, and early, non-invasive diagnosis is crucial to improve outcomes. This study introduces GutSeer, a blood-based assay that combines DNA methylation and fragmentomics for multi-GI cancer detection. Genome-wide methylome profiling identified 1,656 tissue-origin markers across five major GI cancers, forming a targeted bisulfite sequencing panel trained and validated on plasma samples, then evaluated in an independent blinded cohort. Results report high AUC, sensitivity, specificity, and detection of early-stage cancers and advanced precancerous lesions.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/molecular-cancer-guide-a-prospective-cohort-study-for-blood-based-early-detection-of-gastrointestinal-cancers-using-targeted-dna-methylation-and-fragmentomics-sequencing/365752/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/molecular-cancer-guide-a-prospective-cohort-study-for-blood-based-early-detection-of-gastrointestinal-cancers-using-targeted-dna-methylation-and-fragmentomics-sequencing/365752.png","ImageObject",300,407,{"name":92,"@type":93},"Jordan Avery","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"How does GutSeer perform in the validation and independent test cohorts?","Question",{"text":112,"@type":113},"In the validation cohort, GutSeer achieved high AUC with reported sensitivity and specificity, and detected high proportions across multiple GI cancer types. In an independent blinded cohort, it maintained robust performance including detection of early-stage cancers and advanced precancerous lesions.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},365752,1790195555,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":36,"preview_page_count":19,"preview_urls":137},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Huang et al. Molecular Cancer (2025) 24:163 [https://doi.org/10.1186/s12943-025-02367-x](https://doi.org/10.1186/s12943-025-02367-x)  \nMolecular Cancer  \n RESEARCH Open Access  \nGUIDE: a prospective cohort study  \nfor blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing  \nAo Huang1†, De-Zhen Guo 1†, Zhi-Xi Su2†, Yun-Shi Zhong3†, Liang Liu4†, Zhi-Guo Xiong5†, Dong-Li He6,7, Bin Yan8, Quan-Lin Li3, Zhen Feng6,7, Wen-Quan Wang4, Pin-Xiang Lu9, Meng-Jiang He3, Zhi-Peng Qi3, Qi Guo7, Jian-Wen Cheng1, Shi-Yu Zhang1, Wei Guo10, Qing Li11, Guo-Yong Lin 12, Hui-Chuan Sun 1, Shuang-Jian Qiu 1, Qi-Ye He2, Jia Fan1, Ajay Goel13,14, Rui Liu2*, Gang Jin15*, Xin-Rong Yang1* and Jian Zhou1*  \nAbstract  \nBackground Gastrointestinal (GI) cancers are among the most prevalent and lethal malignancies worldwide. Early, non-invasive detection is essential for timely intervention and improved survival. To address this clinical need, we developed GutSeer, a blood-based assay combining DNA methylation and fragmentomics for multi-GI cancer detection.  \nMethods Genome-wide methylome profiling identified 1,656 markers specific to five major GI cancers and their tissue origins. Based on these findings, we designed GutSeer, a targeted bisulfite sequencing panel, which was trained and validated using plasma samples from 1,057 cancer patients and 1,415 non-cancer controls. The locked model was blindly tested in an independent cohort of 846 participants, encompassing both inpatient and outpatient settings across five hospitals.  \nResults In the validation cohort, GutSeer achieved an area under the curve (AUC) of 0.950 [95% Confidence Interval (CI): 0 .937–0. 962] for cancer detection, with 82 . 8% sensitivity (95% CI: 79 .5–86. 0) and 95 . 8% specificity (95% CI:  \n94.3–97. 2) . It detected 92 . 2% of colorectal, 75 . 5% of esophageal, 65 . 3% of gastric, 92 . 9% of liver, and 88. 6% of pancreatic cancers. The independent test cohort included 198 early-stage cancers (stage I/II, 66 .4%) and 63 advanced precancerous lesions. GutSeer maintained robust performance, with 81 . 5% sensitivity (95% CI: 77.1–85. 9) for GI cancers  \n†Ao Huang, De-Zhen Guo, Zhi-Xi Su, Yun-Shi Zhong, Liang Liu and Zhi-Guo Xiong contributed equally to this work.  \n*Correspondence:  \nRui Liu [rliu@singleragenomics.com](rliu@singleragenomics.com)[ ](rliu@singleragenomics.com)Gang Jin [jingang@smmu.edu.cn](jingang@smmu.edu.cn)  \nXin-Rong Yang [yang.xinrong@zs-hospital.sh.cn](yang.xinrong@zs-hospital.sh.cn)[ ](yang.xinrong@zs-hospital.sh.cn)Jian Zhou [zhou.jian@zs-hospital.sh.cn](zhou.jian@zs-hospital.sh.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nHuang et al. Molecular Cancer (2025) 24:163 Page 2 of 16  \nand 94 .4% specificity (95% CI: 92 .4–96. 5) . It also demo","cbCaioCAzT2L5uGc","https://ap.wps.com/l/cbCaioCAzT2L5uGc","pdf",2141125,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Keywords\n# Background","[{\"question\":\"How does GutSeer perform in the validation and independent test cohorts?\",\"answer\":\"In the validation cohort, GutSeer achieved high AUC with reported sensitivity and specificity, and detected high proportions across multiple GI cancer types. In an independent blinded cohort, it maintained robust performance including detection of early-stage cancers and advanced precancerous lesions.\"}]","Molecular Cancer - GUIDE: a prospective cohort study for blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing | PDF",1790162141,[138,142,146,150],{"page_no":8,"url":139,"width":140,"height":141},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3413d3db7fdbce21250491635178d365.webp",983,1305,{"page_no":14,"url":143,"width":144,"height":145},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/541240607b962d15d3cc4dc67fd9d7ef.webp",982,1304,{"page_no":81,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58c97581adba445b127d713a97e7982f.webp",981,1303,{"page_no":19,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6ee4dec6c99415852cf2072300350de0.webp",980,1301]